Key Points
-
Chromosomal instability (CIN), the inability to correctly segregate sister chromatids during mitosis, provides the evolutionary fuel to initiate and propagate the transformed state of multiple forms of cancer.
-
The mitotic checkpoint is seldom lost or weakened in human tumours.
-
Mitotic checkpoint overactivation is a more frequent observation in human tumours and is sufficient to generate CIN in vivo and in vitro. Mitotic checkpoint overactivation results in a prolonged mitosis, abnormal stabilization of cyclin B1 and securin, and an increased incidence of merotelic attachments and lagging chromosomes.
-
Many of the key regulators of the mitotic checkpoint are downstream targets of the Rb tumour suppressor pathway and are therefore upregulated in most human tumours.
-
The consequences of CIN are manifold and context-dependent. Although CIN can initiate tumour formation in many mouse models, under some conditions it decreases cellular fitness, providing a potential tumour suppressor effect. This effect is nevertheless often overcome, giving rise to the karyotypic complexity observed in advanced tumours.
-
Mitotic checkpoint overactivation could prove effective as a novel therapeutic target as mitotic checkpoint loss is incompatible with cellular viability.
Abstract
The stepwise progression from an early dysplastic lesion to full-blown metastatic malignancy is associated with increases in genomic instability. Mitotic chromosomal instability — the inability to faithfully segregate equal chromosome complements to two daughter cells during mitosis — is a widespread phenomenon in solid tumours that is thought to serve as the fuel for tumorigenic progression. How chromosome instability (CIN) arises in tumours and what consequences it has are still, however, hotly debated issues. Here we review the recent literature with an emphasis on models that recapitulate observations from human disease.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
References
Boveri, T. Über mehrpolige mitosen als mittel zur analyse des zellkerns. Verh. Phys. Med. Ges. Würzburg 35, 67–90 (1902).
Boveri, T. Zur Frage der Entstehung Maligner Tumoren (Gustav Fischer, Jena, Germany, 1914).
Ricke, R. M., van Ree, J. H. & van Deursen, J. M. Whole chromosome instability and cancer: a complex relationship. Trends Genet. 24, 457–466 (2008).
Artandi, S. E. et al. Telomere dysfunction promotes non-reciprocal translocations and epithelial cancers in mice. Nature 406, 641–645 (2000).
Garcia-Higuera, I. et al. Genomic stability and tumour suppression by the APC/C cofactor Cdh1. Nature Cell Biol. 10, 802–811 (2008).
Sotillo, R. et al. Mad2 overexpression promotes aneuploidy and tumorigenesis in mice. Cancer Cell 11, 9–23 (2007). The authors show that inducible MAD2L1 overexpression leads to widespread W-CIN and S-CIN in murine fibroblasts and tumour formation when expressed in mice under a ubiquitous promoter.
Cleaver, J. E. Cancer in xeroderma pigmentosum and related disorders of DNA repair. Nature Rev. Cancer 5, 564–573 (2005).
Kunkel, T. A. & Erie, D. A. DNA mismatch repair. Annu. Rev. Biochem. 74, 681–710 (2005).
Rustgi, A. K. The genetics of hereditary colon cancer. Genes Dev. 21, 2525–2538 (2007).
Verdun, R. E. & Karlseder, J. Replication and protection of telomeres. Nature 447, 924–931 (2007).
Lobrich, M. & Jeggo, P. A. The impact of a negligent G2/M checkpoint on genomic instability and cancer induction. Nature Rev. Cancer 7, 861–869 (2007).
Musacchio, A. & Salmon, E. D. The spindle-assembly checkpoint in space and time. Nature Rev. Mol. Cell Biol. 8, 379–393 (2007).
Nasmyth, K. How do so few control so many? Cell 120, 739–746 (2005).
Haering, C. H., Farcas, A. M., Arumugam, P., Metson, J. & Nasmyth, K. The cohesin ring concatenates sister DNA molecules. Nature 454, 297–301 (2008). Cohesin complexes are shown conclusively to topologically link sister chromatids.
Rieder, C. L., Cole, R. W., Khodjakov, A. & Sluder, G. The checkpoint delaying anaphase in response to chromosome monoorientation is mediated by an inhibitory signal produced by unattached kinetochores. J. Cell Biol. 130, 941–948 (1995).
Fang, G., Yu, H. & Kirschner, M. W. The checkpoint protein MAD2 and the mitotic regulator CDC20 form a ternary complex with the anaphase-promoting complex to control anaphase initiation. Genes Dev. 12, 1871–1883 (1998).
Shannon, K. B., Canman, J. C. & Salmon, E. D. Mad2 and BubR1 function in a single checkpoint pathway that responds to a loss of tension. Mol. Biol. Cell 13, 3706–3719 (2002).
Sudakin, V., Chan, G. K. & Yen, T. J. Checkpoint inhibition of the APC/C in HeLa cells is mediated by a complex of BUBR1, BUB3, CDC20, and MAD2. J. Cell Biol. 154, 925–936 (2001).
Wassmann, K. & Benezra, R. Mad2 transiently associates with an APC/p55Cdc complex during mitosis. Proc. Natl Acad. Sci. USA 95, 11193–11198 (1998).
Sudakin, V. et al. The cyclosome, a large complex containing cyclin-selective ubiquitin ligase activity, targets cyclins for destruction at the end of mitosis. Mol. Biol. Cell 6, 185–197 (1995).
De Antoni, A. et al. The Mad1/Mad2 complex as a template for Mad2 activation in the spindle assembly checkpoint. Curr. Biol. 15, 214–225 (2005). In vitro evidence for the MAD2 template model, which suggests an amplification mechanism by which kinetochore-bound MAD2 inhibits the APC/C.
Varetti, G. & Musacchio, A. The spindle assembly checkpoint. Curr. Biol. 18, R591–R595 (2008).
Malureanu, L. A. et al. BubR1 N terminus acts as a soluble inhibitor of cyclin B degradation by APC/C(Cdc20) in interphase. Dev. Cell 16, 118–131 (2009). The authors show that BUBR1 function is dispensable at the kinetochores and is only required in the MCC to inhibit the APC/C.
Braunstein, I., Miniowitz, S., Moshe, Y. & Hershko, A. Inhibitory factors associated with anaphase-promoting complex/cyclosome in mitotic checkpoint. Proc. Natl Acad. Sci. USA 104, 4870–4875 (2007).
Herzog, F. et al. Structure of the anaphase-promoting complex/cyclosome interacting with a mitotic checkpoint complex. Science 323, 1477–1481 (2009). The authors provide structural evidence for the MCC and suggest a mechanism by which it inhibits the APC/C.
Nilsson, J., Yekezare, M., Minshull, J. & Pines, J. The APC/C maintains the spindle assembly checkpoint by targeting Cdc20 for destruction. Nature Cell Biol. 10, 1411–1420 (2008). CDC20 ubiquitylation by the APC/C during an active checkpoint is shown to be required to prevent satisfaction of the mitotic checkpoint.
Wassmann, K., Liberal, V. & Benezra, R. Mad2 phosphorylation regulates its association with Mad1 and the APC/C. EMBO J. 22, 797–806 (2003).
Choi, E. et al. BubR1 acetylation at prometaphase is required for modulating APC/C activity and timing of mitosis. EMBO J. 28, 2077–2089 (2009).
Reddy, S. K., Rape, M., Margansky, W. A. & Kirschner, M. W. Ubiquitination by the anaphase-promoting complex drives spindle checkpoint inactivation. Nature 446, 921–925 (2007).
Stegmeier, F. et al. Anaphase initiation is regulated by antagonistic ubiquitination and deubiquitination activities. Nature 446, 876–881 (2007).
Land, H., Parada, L. F. & Weinberg, R. A. Tumorigenic conversion of primary embryo fibroblasts requires at least two cooperating oncogenes. Nature 304, 596–602 (1983).
Perucho, M. et al. Human-tumor-derived cell lines contain common and different transforming genes. Cell 27, 467–476 (1981).
Chang, E. H., Furth, M. E., Scolnick, E. M. & Lowy, D. R. Tumorigenic transformation of mammalian cells induced by a normal human gene homologous to the oncogene of Harvey murine sarcoma virus. Nature 297, 479–483 (1982).
Goldfarb, M., Shimizu, K., Perucho, M. & Wigler, M. Isolation and preliminary characterization of a human transforming gene from T24 bladder carcinoma cells. Nature 296, 404–409 (1982).
Land, H., Parada, L. F. & Weinberg, R. A. Cellular oncogenes and multistep carcinogenesis. Science 222, 771–778 (1983).
Shih, C., Padhy, L. C., Murray, M. & Weinberg, R. A. Transforming genes of carcinomas and neuroblastomas introduced into mouse fibroblasts. Nature 290, 261–264 (1981).
Pei, L. & Melmed, S. Isolation and characterization of a pituitary tumor-transforming gene (PTTG). Mol. Endocrinol. 11, 433–441 (1997).
Vader, G. & Lens, S. M. The Aurora kinase family in cell division and cancer. Biochim. Biophys. Acta 1786, 60–72 (2008).
Katayama, H., Brinkley, W. R. & Sen, S. The Aurora kinases: role in cell transformation and tumorigenesis. Cancer Metastasis Rev. 22, 451–464 (2003).
Zhang, D. et al. Cre–loxP-controlled periodic Aurora-A overexpression induces mitotic abnormalities and hyperplasia in mammary glands of mouse models. Oncogene 23, 8720–8730 (2004).
Lee, S. H., Sterling, H., Burlingame, A. & McCormick, F. Tpr directly binds to Mad1 and Mad2 and is important for the Mad1–Mad2-mediated mitotic spindle checkpoint. Genes Dev. 22, 2926–2931 (2008).
Dawlaty, M. M. et al. Resolution of sister centromeres requires RanBP2-mediated SUMOylation of topoisomerase IIα. Cell 133, 103–115 (2008).
Bernal, J. A. et al. Human securin interacts with p53 and modulates p53-mediated transcriptional activity and apoptosis. Nature Genet. 32, 306–311 (2002).
Fang, Y. et al. BubR1 is involved in regulation of DNA damage responses. Oncogene 25, 3598–3605 (2006).
Hein, J. et al. Simian virus 40 large T antigen disrupts genome integrity and activates a DNA damage response via Bub1 binding. J. Virol. 83, 117–127 (2009).
Carter, S. L., Eklund, A. C., Kohane, I. S., Harris, L. N. & Szallasi, Z. A signature of chromosomal instability inferred from gene expression profiles predicts clinical outcome in multiple human cancers. Nature Genet. 38, 1043–1048 (2006). Transcriptional analysis of human aneuploid tumours reveals a signature of CIN that has prognostic power independent of its relationship to cell cycle progression.
Kronenwett, U. et al. Improved grading of breast adenocarcinomas based on genomic instability. Cancer Res. 64, 904–909 (2004).
Rhodes, D. R. et al. ONCOMINE: a cancer microarray database and integrated data-mining platform. Neoplasia 6, 1–6 (2004).
Dobles, M., Liberal, V., Scott, M. L., Benezra, R. & Sorger, P. K. Chromosome missegregation and apoptosis in mice lacking the mitotic checkpoint protein Mad2. Cell 101, 635–645 (2000).
Baker, D. J. et al. BubR1 insufficiency causes early onset of aging-associated phenotypes and infertility in mice. Nature Genet. 36, 744–749 (2004).
Dai, W. et al. Slippage of mitotic arrest and enhanced tumor development in mice with BubR1 haploinsufficiency. Cancer Res. 64, 440–445 (2004).
Babu, J. R. et al. Rae1 is an essential mitotic checkpoint regulator that cooperates with Bub3 to prevent chromosome missegregation. J. Cell Biol. 160, 341–353 (2003).
Kalitsis, P., Earle, E., Fowler, K. J. & Choo, K. H. Bub3 gene disruption in mice reveals essential mitotic spindle checkpoint function during early embryogenesis. Genes Dev. 14, 2277–2282 (2000).
Jeganathan, K., Malureanu, L., Baker, D. J., Abraham, S. C. & van Deursen, J. M. Bub1 mediates cell death in response to chromosome missegregation and acts to suppress spontaneous tumorigenesis. J. Cell Biol. 179, 255–267 (2007).
Weaver, B. A., Silk, A. D., Montagna, C., Verdier-Pinard, P. & Cleveland, D. W. Aneuploidy acts both oncogenically and as a tumor suppressor. Cancer Cell 11, 25–36 (2006).
Li, M., Fang, X., Wei, Z., York, J. P. & Zhang, P. Loss of spindle assembly checkpoint-mediated inhibition of Cdc20 promotes tumorigenesis in mice. J. Cell Biol. 185, 983–994 (2009).
Pérez de Castro, I., de Cárcer, G. & Malumbres, M. A census of mitotic cancer genes: new insights into tumor cell biology and cancer therapy. Carcinogenesis 28, 899–912 (2007).
Perera, D. et al. Bub1 maintains centromeric cohesion by activation of the spindle checkpoint. Dev. Cell 13, 566–579 (2007).
Jeong, S. J. et al. Transcriptional abnormality of the hsMAD2 mitotic checkpoint gene is a potential link to hepatocellular carcinogenesis. Cancer Res. 64, 8666–8673 (2004).
Sze, K. M., Ching, Y. P., Jin, D. Y. & Ng, I. O. Association of MAD2 expression with mitotic checkpoint competence in hepatoma cells. J. Biomed. Sci. 11, 920–927 (2004).
Wang, X. et al. Significance of MAD2 expression to mitotic checkpoint control in ovarian cancer cells. Cancer Res. 62, 1662–1668 (2002).
Wang, X. et al. Correlation of defective mitotic checkpoint with aberrantly reduced expression of MAD2 protein in nasopharyngeal carcinoma cells. Carcinogenesis 21, 2293–2297 (2000).
Ren, B. et al. E2F integrates cell cycle progression with DNA repair, replication, and G2/M checkpoints. Genes Dev. 16, 245–56 (2002).
Hanks, S. et al. Constitutional aneuploidy and cancer predisposition caused by biallelic mutations in BUB1B. Nature Genet. 36, 1159 (2004).
Gascoigne, K. E. & Taylor, S. S. Cancer cells display profound intra- and interline variation following prolonged exposure to antimitotic drugs. Cancer Cell 14, 111–122 (2008).
Tighe, A., Johnson, V. L., Albertella, M. & Taylor, S. S. Aneuploid colon cancer cells have a robust spindle checkpoint. EMBO Rep. 2, 609–614 (2001). References 65 and 66 provide evidence for a strong mitotic checkpoint in tumour cell lines and provide a mechanistic model for mitotic slippage.
Rhodes, D. R. et al. Oncomine 3.0: genes, pathways, and networks in a collection of 18,000 cancer gene expression profiles. Neoplasia 9, 166–180 (2007).
Hernando, E. et al. Rb inactivation promotes genomic instability by uncoupling cell cycle progression from mitotic control. Nature 430, 797–802 (2004).
Lengauer, C., Kinzler, K. W. & Vogelstein, B. Genetic instability in colorectal cancers. Nature 386, 623–627 (1997).
Nicholson, J. M. & Duesberg, P. On the karyotypic origin and evolution of cancer cells. Cancer Genet. Cytogenet. 194, 96–110 (2009).
Diaz-Rodriguez, E., Sotillo, R., Schvartzman, J. M. & Benezra, R. Hec1 overexpression hyperactivates the mitotic checkpoint and induces tumor formation in vivo. Proc. Natl Acad. Sci. USA 105, 16719–16724 (2008). The authors show that overexpression of HEC1, an essential component of the kinetochore complex, leads to mitotic checkpoint overactivation, CIN and tumorigenesis in mice.
Thompson, S. L. & Compton, D. A. Examining the link between chromosomal instability and aneuploidy in human cells. J. Cell Biol. 180, 665–672 (2008). Chemical overactivation of the mitotic checkpoint is shown to generate lagging chromosomes and aneuploidy, which are selected against in non-tumorigenic cell lines.
Rieder, C. L. & Maiato, H. Stuck in division or passing through: what happens when cells cannot satisfy the spindle assembly checkpoint. Dev. Cell 7, 637–651 (2004).
Brito, D. A. & Rieder, C. L. Mitotic checkpoint slippage in humans occurs via cyclin B destruction in the presence of an active checkpoint. Curr. Biol. 16, 1194–1200 (2006). Mitotic slippage is shown to occur in an APC/C dependent manner in the presence of checkpoint activity.
Iovino, F., Lentini, L., Amato, A. & Di Leonardo, A. RB acute loss induces centrosome amplification and aneuploidy in murine primary fibroblasts. Mol. Cancer 5, 38 (2006).
Lentini, L., Iovino, F., Amato, A. & Di Leonardo, A. Centrosome amplification induced by hydroxyurea leads to aneuploidy in pRB deficient human and mouse fibroblasts. Cancer Lett. 238, 153–160 (2006).
Lentini, L., Pipitone, L. & Di Leonardo, A. Functional inactivation of pRB results in aneuploid mammalian cells after release from a mitotic block. Neoplasia 4, 380–387 (2002).
Mayhew, C. N. et al. RB loss abrogates cell cycle control and genome integrity to promote liver tumorigenesis. Gastroenterology 133, 976–984 (2007).
Zheng, L., Flesken-Nikitin, A., Chen, P. L. & Lee, W. H. Deficiency of retinoblastoma gene in mouse embryonic stem cells leads to genetic instability. Cancer Res. 62, 2498–2502 (2002).
Quintyne, N. J., Reing, J. E., Hoffelder, D. R., Gollin, S. M. & Saunders, W. S. Spindle multipolarity is prevented by centrosomal clustering. Science 307, 127–129 (2005).
Kwon, M. et al. Mechanisms to suppress multipolar divisions in cancer cells with extra centrosomes. Genes Dev. 22, 2189–2203 (2008).
Silkworth, W. T., Nardi, I. K., Scholl, L. M. & Cimini, D. Multipolar spindle pole coalescence is a major source of kinetochore mis-attachment and chromosome mis-segregation in cancer cells. PLoS ONE 4, e6564 (2009).
Ganem, N. J., Godinho, S. A. & Pellman, D. A mechanism linking extra centrosomes to chromosomal instability. Nature 460, 278–282 (2009).
Iwanaga, Y. et al. Heterozygous deletion of mitotic arrest-deficient protein 1 (MAD1) increases the incidence of tumors in mice. Cancer Res. 67, 160–166 (2007).
Ko, M. A. et al. Plk4 haploinsufficiency causes mitotic infidelity and carcinogenesis. Nature Genet. 37, 883–888 (2005).
Holland, A. J. & Cleveland, D. W. Boveri revisited: chromosomal instability, aneuploidy and tumorigenesis. Nature Rev. Mol. Cell Biol. 10, 478–487 (2009).
Wang, X. et al. Overexpression of aurora kinase A in mouse mammary epithelium induces genetic instability preceding mammary tumor formation. Oncogene 25, 7148–7158 (2006).
Swanton, C. et al. Chromosomal instability determines taxane response. Proc. Natl Acad. Sci. USA 106, 8671–8676 (2009).
Malumbres, M. & Barbacid, M. RAS oncogenes: the first 30 years. Nature Rev. Cancer 3, 459–465 (2003).
Meyer, N. & Penn, L. Z. Reflecting on 25 years with MYC. Nature Rev. Cancer 8, 976–990 (2008).
Donehower, L. A. et al. Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature 356, 215–221 (1992).
Jacks, T. et al. Effects of an Rb mutation in the mouse. Nature 359, 295–300 (1992).
Williams, B. R. et al. Aneuploidy affects proliferation and spontaneous immortalization in mammalian cells. Science 322, 703–709 (2008). Trisomy generated by Robertsonian translocations is shown to be detrimental to the viability of primary cell lines.
Gonzalo, S. et al. Role of the RB1 family in stabilizing histone methylation at constitutive heterochromatin. Nature Cell Biol. 7, 420–428 (2005).
Rao, C. V. et al. Colonic tumorigenesis in BubR1+/− ApcMin/+ compound mutant mice is linked to premature separation of sister chromatids and enhanced genomic instability. Proc. Natl Acad. Sci. USA 102, 4365–4370 (2005).
Jordan, M. A. & Wilson, L. Microtubules as a target for anticancer drugs. Nature Rev. Cancer 4, 253–265 (2004).
Huang, H. C., Shi, J., Orth, J. D. & Mitchison, T. J. Evidence that mitotic exit is a better cancer therapeutic target than spindle assembly. Cancer Cell 16, 347–358 (2009).
Weinert, T. A. & Hartwell, L. H. The RAD9 gene controls the cell cycle response to DNA damage in Saccharomyces cerevisiae. Science 241, 317–322 (1988).
Weinert, T. & Hartwell, L. Control of G2 delay by the rad9 gene of Saccharomyces cerevisiae. J. Cell Sci. 12 (Suppl.), 145–148 (1989).
Li, R. & Murray, A. Feedback control of mitosis in budding yeast. Cell 66, 519–531 (1991).
Hoyt, M. A., Totis, L. & Roberts, B. T. S. cerevisiae genes required for cell cycle arrest in response to loss of microtubule function. Cell 66, 507–517 (1991).
Li, Y. & Benezra, R. Identification of a human mitotic checkpoint gene: hsMAD2. Science 274, 246–248 (1996). References 101 and 102 were the first to identify mitotic checkpoint genes.
Kops, G. J., Foltz, D. R. & Cleveland, D. W. Lethality to human cancer cells through massive chromosome loss by inhibition of the mitotic checkpoint. Proc. Natl Acad. Sci. USA 101, 8699–8704 (2004).
Michel, L. S. et al. MAD2 haplo-insufficiency causes premature anaphase and chromosome instability in mammalian cells. Nature 409, 355–359 (2001). References 103 and 104 show that, unlike the case for the G2/M DNA damage checkpoint and the mitotic checkpoint in budding yeast, the mitotic checkpoint in vertebrates is essential for cell viability.
Meraldi, P., Draviam, V. M. & Sorger, P. K. Timing and checkpoints in the regulation of mitotic progression. Dev. Cell 7, 45–60 (2004).
Zhou, H. et al. Tumour amplified kinase STK15/BTAK induces centrosome amplification, aneuploidy and transformation. Nature Genet. 20, 189–193 (1998).
Sen, S. et al. Amplification/overexpression of a mitotic kinase gene in human bladder cancer. J. Natl Cancer Inst. 94, 1320–1329 (2002).
Bischoff, J. R. et al. A homologue of Drosophila aurora kinase is oncogenic and amplified in human colorectal cancers. EMBO J. 17, 3052–3065 (1998).
Miyoshi, Y., Iwao, K., Egawa, C. & Noguchi, S. Association of centrosomal kinase STK15/BTAK mRNA expression with chromosomal instability in human breast cancers. Int. J. Cancer 92, 370–373 (2001).
Baba, Y. et al. Aurora-A expression is independently associated with chromosomal instability in colorectal cancer. Neoplasia 11, 418–4125 (2009).
Gritsko, T. M. et al. Activation and overexpression of centrosome kinase BTAK/Aurora-A in human ovarian cancer. Clin. Cancer Res. 9, 1420–1426 (2003).
Ablikim, M. et al. Observation of Y(2175) in J/σπ psi →etaphif0 (980). Phys. Rev. Lett. 100, 102003 (2008).
Sakakura, C. et al. Tumour-amplified kinase BTAK is amplified and overexpressed in gastric cancers with possible involvement in aneuploid formation. Br. J. Cancer 84, 824–831 (2001).
Twu, N. F. et al. Expression of Aurora kinase A and B in normal and malignant cervical tissue: high Aurora A kinase expression in squamous cervical cancer. Eur. J. Obstet. Gynecol. Reprod. Biol. 142, 57–63 (2009).
Reiter, R. et al. Aurora kinase A messenger RNA overexpression is correlated with tumor progression and shortened survival in head and neck squamous cell carcinoma. Clin. Cancer Res. 12, 5136–5141 (2006).
Lu, L. Y. et al. Aurora A is essential for early embryonic development and tumor suppression. J. Biol. Chem. 283, 31785–31790 (2008).
Cowley, D. O. et al. Aurora-A kinase is essential for bipolar spindle formation and early development. Mol. Cell Biol. 29, 1059–1071 (2009).
Araki, K., Nozaki, K., Ueba, T., Tatsuka, M. & Hashimoto, N. High expression of Aurora-B/Aurora and Ipll-like midbody-associated protein (AIM-1) in astrocytomas. J. Neurooncol. 67, 53–64 (2004).
Chieffi, P. et al. Aurora B expression in normal testis and seminomas. J. Endocrinol. 181, 263–270 (2004).
Gibson, S. E., Zeng, W. F., Weil, R. J. & Prayson, R. A. Aurora B kinase expression in ependymal neoplasms. Appl. Immunohistochem. Mol. Morphol. 16, 274–278 (2008).
Chieffi, P. et al. Aurora B expression directly correlates with prostate cancer malignancy and influence prostate cell proliferation. Prostate 66, 326–333 (2006).
Smith, S. L. et al. Overexpression of aurora B kinase (AURKB) in primary non-small cell lung carcinoma is frequent, generally driven from one allele, and correlates with the level of genetic instability. Br. J. Cancer 93, 719–729 (2005).
Tanaka, S. et al. Aurora kinase B is a predictive factor for the aggressive recurrence of hepatocellular carcinoma after curative hepatectomy. Br. J. Surg. 95, 611–619 (2008).
Nguyen, H. G. et al. Deregulated Aurora-B induced tetraploidy promotes tumorigenesis. FASEB J. 23, 2741–2748 (2009).
Gemma, A. et al. Somatic mutation of the hBUB1 mitotic checkpoint gene in primary lung cancer. Genes Chromosomes Cancer 29, 213–218 (2000).
Hempen, P. M., Kurpad, H., Calhoun, E. S., Abraham, S. & Kern, S. E. A double missense variation of the BUB1 gene and a defective mitotic spindle checkpoint in the pancreatic cancer cell line Hs766T. Hum. Mutat. 21, 445 (2003).
Shichiri, M., Yoshinaga, K., Hisatomi, H., Sugihara, K. & Hirata, Y. Genetic and epigenetic inactivation of mitotic checkpoint genes hBUB1 and hBUBR1 and their relationship to survival. Cancer Res. 62, 713–717 (2002).
Lin, S. F. et al. Expression of hBUB1 in acute myeloid leukemia. Leuk. Lymphoma 43, 385–391 (2002).
Yuan, B. et al. Increased expression of mitotic checkpoint genes in breast cancer cells with chromosomal instability. Clin. Cancer Res. 12, 405–410 (2006).
Moreno-Bueno, G. et al. Differential gene expression profile in endometrioid and nonendometrioid endometrial carcinoma: STK15 is frequently overexpressed and amplified in nonendometrioid carcinomas. Cancer Res. 63, 5697–5702 (2003).
Grabsch, H. et al. Overexpression of the mitotic checkpoint genes BUB1, BUBR1, and BUB3 in gastric cancer — association with tumour cell proliferation. J. Pathol. 200, 16–22 (2003).
Pinto, M. et al. Overexpression of the mitotic checkpoint genes BUB1 and BUBR1 is associated with genomic complexity in clear cell kidney carcinomas. Cell Oncol. 30, 389–395 (2008).
Wada, N. et al. Overexpression of the mitotic spindle assembly checkpoint genes hBUB1, hBUBR1 and hMAD2 in thyroid carcinomas with aggressive nature. Anticancer Res. 28, 139–144 (2008).
Cahill, D. P. et al. Mutations of mitotic checkpoint genes in human cancers. Nature 392, 300–303 (1998).
Schliekelman, M. et al. Impaired Bub1 function in vivo compromises tension-dependent checkpoint function leading to aneuploidy and tumorigenesis. Cancer Res. 69, 45–54 (2009).
Baker, D. J. et al. Early aging-associated phenotypes in Bub3/Rae1 haploinsufficient mice. J. Cell Biol. 172, 529–540 (2006).
Kalitsis, P. et al. Increased chromosome instability but not cancer predisposition in haploinsufficient Bub3 mice. Genes Chromosomes Cancer 44, 29–36 (2005).
Mondal, G. et al. Overexpression of Cdc20 leads to impairment of the spindle assembly checkpoint and aneuploidization in oral cancer. Carcinogenesis 28, 81–92 (2007).
Li, D. et al. Overexpression of oncogenic STK15/BTAK/Aurora A kinase in human pancreatic cancer. Clin. Cancer Res. 9, 991–997 (2003).
Kim, J. M. et al. Identification of gastric cancer-related genes using a cDNA microarray containing novel expressed sequence tags expressed in gastric cancer cells. Clin. Cancer Res. 11, 473–482 (2005).
Ouellet, V. et al. Tissue array analysis of expression microarray candidates identifies markers associated with tumor grade and outcome in serous epithelial ovarian cancer. Int. J. Cancer 119, 599–607 (2006).
Marucci, G. et al. Gene expression profiling in glioblastoma and immunohistochemical evaluation of IGFBP-2 and CDC20. Virchows Arch. 453, 599–609 (2008).
Singhal, S. et al. Alterations in cell cycle genes in early stage lung adenocarcinoma identified by expression profiling. Cancer Biol. Ther. 2, 291–298 (2003).
Fujita, T., Liu, W., Doihara, H. & Wan, Y. Regulation of Skp2–p27 axis by the Cdh1/anaphase-promoting complex pathway in colorectal tumorigenesis. Am. J. Pathol. 173, 217–228 (2008).
Lehman, N. L. et al. Oncogenic regulators and substrates of the anaphase promoting complex/cyclosome are frequently overexpressed in malignant tumors. Am. J. Pathol. 170, 1793–1805 (2007).
Wierinckx, A. et al. A diagnostic marker set for invasion, proliferation, and aggressiveness of prolactin pituitary tumors. Endocr. Relat. Cancer 14, 887–900 (2007).
Weaver, B. A. & Cleveland, D. W. Aneuploidy: instigator and inhibitor of tumorigenesis. Cancer Res. 67, 10103–10105 (2007).
Weaver, B. A., Silk, A. D., Montagna, C., Verdier-Pinard, P. & Cleveland, D. W. Aneuploidy acts both oncogenically and as a tumor suppressor. Cancer Cell 11, 25–36 (2007).
Wikman, H. et al. Identification of differentially expressed genes in pulmonary adenocarcinoma by using cDNA array. Oncogene 21, 5804–5813 (2002).
Kettunen, E. et al. Differentially expressed genes in nonsmall cell lung cancer: expression profiling of cancer-related genes in squamous cell lung cancer. Cancer Genet. Cytogenet. 149, 98–106 (2004).
Soria, J. C. et al. Overexpression of cyclin B1 in early-stage non-small cell lung cancer and its clinical implication. Cancer Res. 60, 4000–4004 (2000).
Koon, N. et al. Molecular targets for tumour progression in gastrointestinal stromal tumours. Gut 53, 235–240 (2004).
Takeno, S. et al. Prognostic value of cyclin B1 in patients with esophageal squamous cell carcinoma. Cancer 94, 2874–2881 (2002).
Yoshida, T., Tanaka, S., Mogi, A., Shitara, Y. & Kuwano, H. The clinical significance of Cyclin B1 and Wee1 expression in non-small-cell lung cancer. Ann. Oncol. 15, 252–256 (2004).
Ikuerowo, S. O. et al. Alteration of subcellular and cellular expression patterns of cyclin B1 in renal cell carcinoma is significantly related to clinical progression and survival of patients. Int. J. Cancer 119, 867–874 (2006).
Agarwal, R. et al. Integrative analysis of cyclin protein levels identifies cyclin b1 as a classifier and predictor of outcomes in breast cancer. Clin. Cancer Res. 15, 3654–3662 (2009).
Aaltonen, K. et al. High cyclin B1 expression is associated with poor survival in breast cancer. Br. J. Cancer 100, 1055–1060 (2009).
Brandeis, M. et al. Cyclin B2-null mice develop normally and are fertile whereas cyclin B1-null mice die in utero. Proc. Natl Acad. Sci. USA 95, 4344–4349 (1998).
Hayama, S. et al. Activation of CDCA1–KNTC2, members of centromere protein complex, involved in pulmonary carcinogenesis. Cancer Res. 66, 10339–10348 (2006).
Perez de Castro, I., de Carcer, G. & Malumbres, M. A census of mitotic cancer genes: new insights into tumor cell biology and cancer therapy. Carcinogenesis 28, 899–912 (2007).
Nomoto, S. et al. Search for in vivo somatic mutations in the mitotic checkpoint gene, hMAD1, in human lung cancers. Oncogene 18, 7180–7183 (1999).
Tsukasaki, K. et al. Mutations in the mitotic check point gene, MAD1L1, in human cancers. Oncogene 20, 3301–3305 (2001).
Nishigaki, R. et al. Proteomic identification of differentially-expressed genes in human gastric carcinomas. Proteomics 5, 3205–3213 (2005).
Han, S. et al. Clinical implication of altered expression of Mad1 protein in human breast carcinoma. Cancer 88, 1623–1632 (2000).
Nam, C. W. et al. Mitotic checkpoint gene MAD1 in hepatocellular carcinoma is associated with tumor recurrence after surgical resection. J. Surg. Oncol. 97, 567–571 (2008).
Chi, Y. H., Ward, J. M., Cheng, L. I., Yasunaga, J. & Jeang, K. T. Spindle assembly checkpoint and p53 deficiencies cooperate for tumorigenesis in mice. Int. J. Cancer 124, 1483–1489 (2009).
Hernando, E. et al. Molecular analyses of the mitotic checkpoint components hsMAD2, hBUB1 and hBUB3 in human cancer. Int. J. Cancer 95, 223–227 (2001).
Percy, M. J. et al. Expression and mutational analyses of the human MAD2L1 gene in breast cancer cells. Genes Chromosomes Cancer 29, 356–362 (2000).
Alizadeh, A. A. et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 403, 503–511 (2000).
Chen, X. et al. Gene expression patterns in human liver cancers. Mol. Biol. Cell 13, 1929–1939 (2002).
Garber, M. E. et al. Diversity of gene expression in adenocarcinoma of the lung. Proc. Natl Acad. Sci. USA 98, 13784–13789 (2001).
Heighway, J. et al. Expression profiling of primary non-small cell lung cancer for target identification. Oncogene 21, 7749–7763 (2002).
Hisaoka, M., Matsuyama, A. & Hashimoto, H. Aberrant MAD2 expression in soft-tissue sarcoma. Pathol. Int. 58, 329–333 (2008).
Wang, L. et al. MAD2 as a key component of mitotic checkpoint: a probable prognostic factor for gastric cancer. Am. J. Clin. Pathol. 131, 793–801 (2009).
Rimkus, C. et al. Expression of the mitotic checkpoint gene MAD2L2 has prognostic significance in colon cancer. Int. J. Cancer 120, 207–211 (2007).
Grutzmann, R. et al. Gene expression profiling of microdissected pancreatic ductal carcinomas using high-density DNA microarrays. Neoplasia 6, 611–622 (2004).
Saez, C. et al. hpttg is over-expressed in pituitary adenomas and other primary epithelial neoplasias. Oncogene 18, 5473–5476 (1999).
Honda, S. et al. A role for the pituitary tumor-transforming gene in the genesis and progression of non-small cell lung carcinomas. Anticancer Res. 23, 3775–3782 (2003).
Genkai, N., Homma, J., Sano, M., Tanaka, R. & Yamanaka, R. Increased expression of pituitary tumor-transforming gene (PTTG)-1 is correlated with poor prognosis in glioma patients. Oncol. Rep. 15, 1569–1574 (2006).
Fujii, T. et al. Overexpression of pituitary tumor transforming gene 1 in HCC is associated with angiogenesis and poor prognosis. Hepatology 43, 1267–1275 (2006).
Su, M. C., Hsu, H. C., Liu, Y. J. & Jeng, Y. M. Overexpression of pituitary tumor-transforming gene-1 in hepatocellular carcinoma. Hepatogastroenterology 53, 262–265 (2006).
Zhu, X. et al. Significance of pituitary tumor transforming gene 1 (PTTG1) in prostate cancer. Anticancer Res. 26, 1253–1259 (2006).
Puri, R., Tousson, A., Chen, L. & Kakar, S. S. Molecular cloning of pituitary tumor transforming gene 1 from ovarian tumors and its expression in tumors. Cancer Lett. 163, 131–139 (2001).
Heaney, A. P. et al. Expression of pituitary-tumour transforming gene in colorectal tumours. Lancet 355, 716–719 (2000).
Liang, H. S. et al. Comparative analysis of protein expression in differentiated thyroid tumours: a multicentre study. J. Int. Med. Res. 37, 927–938 (2009).
Chiriva-Internati, M. et al. The pituitary tumor transforming gene 1 (PTTG-1): an immunological target for multiple myeloma. J. Transl. Med. 6, 15 (2008).
Ramaswamy, S., Ross, K. N., Lander, E. S. & Golub, T. R. A molecular signature of metastasis in primary solid tumors. Nature Genet. 33, 49–54 (2003).
Yan, S. et al. PTTG overexpression promotes lymph node metastasis in human esophageal squamous cell carcinoma. Cancer Res. 69, 3283–3290 (2009).
Wang, Z., Yu, R. & Melmed, S. Mice lacking pituitary tumor transforming gene show testicular and splenic hypoplasia, thymic hyperplasia, thrombocytopenia, aberrant cell cycle progression, and premature centromere division. Mol. Endocrinol. 15, 1870–1879 (2001).
Chesnokova, V., Kovacs, K., Castro, A. V., Zonis, S. & Melmed, S. Pituitary hypoplasia in Pttg−/− mice is protective for Rb+/− pituitary tumorigenesis. Mol. Endocrinol. 19, 2371–2379 (2005).
Abbud, R. A. et al. Early multipotential pituitary focal hyperplasia in the α-subunit of glycoprotein hormone-driven pituitary tumor-transforming gene transgenic mice. Mol. Endocrinol. 19, 1383–1391 (2005).
Donangelo, I. et al. Pituitary tumor transforming gene overexpression facilitates pituitary tumor development. Endocrinology 147, 4781–4791 (2006).
Simizu, S. & Osada, H. Mutations in the Plk gene lead to instability of Plk protein in human tumour cell lines. Nature Cell Biol. 2, 852–854 (2000).
Tokumitsu, Y. et al. Prognostic significance of polo-like kinase expression in esophageal carcinoma. Int. J. Oncol. 15, 687–692 (1999).
Wolf, G. et al. Prognostic significance of polo-like kinase (PLK) expression in non-small cell lung cancer. Oncogene 14, 543–549 (1997).
Macmillan, J. C., Hudson, J. W., Bull., S., Dennis, J. W. & Swallow, C. J. Comparative expression of the mitotic regulators SAK and PLK in colorectal cancer. Ann. Surg. Oncol. 8, 729–740 (2001).
Nappi, T. C. et al. Identification of Polo-like kinase 1 as a potential therapeutic target in anaplastic thyroid carcinoma. Cancer Res. 69, 1916–1923 (2009).
Lu, L. Y. et al. Polo-like kinase 1 is essential for early embryonic development and tumor suppression. Mol. Cell Biol. 28, 6870–6876 (2008).
Jackson, J. R., Patrick, D. R., Dar, M. M. & Huang, P. S. Targeted anti-mitotic therapies: can we improve on tubulin agents? Nature Rev. Cancer 7, 107–117 (2007).
Sotillo, R., Schvartzman, J. M., Socci, N. D. & Benezra, R. Mad2-induced chromosome instability leads to lung tumor relapse after oncogene withdrawal. Nature (in the press).
Acknowledgements
We apologize to those authors whose work is not cited because of space limitations. We would like to thank A. Unni and W. Forrester for helpful discussions of the manuscript. J.M.S. is supported by a Breast Cancer Research Program Predoctoral Traineeship Award from the Department of Defense (Congressionally Directed Medical Research Program). R.S. was supported by the Charles H. Revson Foundation. R.B. is supported by the National Institutes of Health.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Related links
Related links
DATABASES
OMIM
FURTHER INFORMATION
Glossary
- Chromosome instability
-
The inability to maintain a correct chromosome complement after cell division.
- Aneuploidy
-
An abnormal chromosome number.
- Mitotic checkpoint
-
A cell cycle checkpoint that arrests cell division at metaphase until all sister kinetochores are attached to microtubules from opposite spindle poles.
- Breakage–fusion–bridge cycles
-
A process of amplification in which two centromeres of a dicentric chromosome are pulled to opposite poles during mitosis. If the chromosome breaks then the double-stranded breaks persist in the following S-phase and can contribute to translocations or form new dicentric chromosomes that continue the process of instability.
- Whole chromosome instability
-
This describes CIN in terms of abnormal numbers of chromosomes.
- Segmental chromosome instability
-
This describes CIN in terms of structural abnormalities, such as translocations, inversions, interstitial deletions and amplifications.
- Kinetochore
-
The protein complex that assembles around centromeric chromosome regions and is the source of the signal that activates the mitotic checkpoint and the site of spindle fibre attachment.
- Spindle pole
-
The site of origin of microtubule fibres in mitosis. In most cells this site is delineated by the presence of centrosomes that act as microtubule organizing centers.
- Cohesin
-
A protein complex composed of structural maintenance of chromosomes 1A (SMC1A), SMC3, sister chromatid cohesion 1 (SSC1, also known as RAD21) and SSC3 (also known as stromal antigen 1), the function of which is to topologically link sister chromatids before metaphase.
- Anaphase promoting complex/cyclosome
-
A large E3 ubiquitin ligase complex that degrades cyclin B1 and securin once the mitotic checkpoint is satisfied.
- Spindle poison
-
A compound that affects microtubule function and therefore mitotic spindle formation by stabilizing (such as taxanes) or depolymerizing (such as vinka alkaloids or nocodazole) microtubules.
- Transformation
-
A mechanistically defined process in which a primary cell acquires the ability togrow indefinitely in vitro (immortalization), form colonies in soft agar (anchorage-independent growth) and form tumour xenografts when implanted intradermally in nude mice.
- Microcephaly
-
An abnormally small head circumference, which usually results from abnormal brain development.
- Mosaic aneuploidy
-
A tissue in which groups of cells contain chromosome complements that differ from those of neighbouring cells.
- Merotelic attachment
-
When a single kinetochore is attached to microtubules from two spindle poles rather than to one pole.
- Mitotic slippage
-
The process by which a cell arrested in mitosis proceeds through anaphase despite an active mitotic checkpoint.
- Monastrol
-
A small molecule inhibitor of the plus-end directed KIF11 kinesin motor, the function of which is required for chromosome segregation in mitosis.
- Nocodazole
-
A chemical inhibitor of microtubule polymerization often used to activate the mitotic checkpoint and therefore arrest cells in the G2/M phase of the cell cycle.
- Lagging chromosome
-
In anaphase, pairs of sister chromatids that remain at the metaphase plate, often as a consequence of merotelic attachment, can be the source of aneuploidy in the resulting daughter cells. This is distinct from a single chromatid that fails to segregate upon disjunction from its sister chromatid.
- Chromosome bridge
-
In anaphase, a chromosome that bridges the two separating daughter nuclei as a result of abnormal attachments.
- Robertsonian translocation
-
A non-reciprocal chromosomal translocation in which two distinct acrocentric chromosomes become fused and share a single centromere.
- DMBA-induced tumour
-
An induced tumour model in mice in which the carcinogen DMBA (7,12-dimethylbenz(a)anthracene) is applied to the skin of 5–7 day old pups. This results in the appearance of skin and lung tumours once animals reach adulthood.
- Array-comparative genomic hybridization
-
A genomic DNA hybridization technique that allows high-resolution analysis of copy number changes between two populations (such as normal versus tumour DNA).
- Non-cell-autonomous effect
-
A phenotypic effect seen in a field of cells that are mediated by cells that are not part of that field, such as the clearance of tumour cells by bone marrow cells or cells of the tumour microenvironment.
Rights and permissions
About this article
Cite this article
Schvartzman, JM., Sotillo, R. & Benezra, R. Mitotic chromosomal instability and cancer: mouse modelling of the human disease. Nat Rev Cancer 10, 102–115 (2010). https://doi.org/10.1038/nrc2781
Issue Date:
DOI: https://doi.org/10.1038/nrc2781
This article is cited by
-
FOXM1 is critical for the fitness recovery of chromosomally unstable cells
Cell Death & Disease (2023)
-
E3-ubiquitin ligase, FBXW7 regulates mitotic progression by targeting BubR1 for ubiquitin-mediated degradation
Cellular and Molecular Life Sciences (2023)
-
Modeling specific aneuploidies: from karyotype manipulations to biological insights
Chromosome Research (2023)
-
Genomic instability genes in lung and colon adenocarcinoma indicate organ specificity of transcriptomic impact on Copy Number Alterations
Scientific Reports (2022)
-
Effects of aneuploidy on cell behaviour and function
Nature Reviews Molecular Cell Biology (2022)